Clinical Trial: A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2
Study Status: Completed
Recruit Status: RECRUITING
Condition: Stable Nonsegmental Vitiligo
Study Type: INTERVENTIONAL
Official Title: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBO-CONTROLLED MULTI-CENTER STUDY WITH A DOUBLE-BLIND 52-WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UP/DOSE DOWN TITRATION INVESTIGATING THE EFFICA
Brief Summary:
The purpose of this study is to learn about the safety and effects of the study medicine ritlecitinib for the possible treatment of nonsegmental vitiligo.Vitiligo causes white patches on your skin when the cells that give your skin color are destroyed.Nonsegmental means that it can affect both sides of the body such as both knees and both hands.Ritlecitinib has been tested in earlier clinical studies and has a favorable safety profile.At present there are no approved medications taken by mouth to treat…
Read more